Monday 12 October 2026 Export all AMGN data to Excel Powerpack

Amgen Inc.

AMGN Healthcare Drug Manufacturers General

Amgen Inc.’s revenue for fiscal 2025 (year ended December 2025) was $36.8 billion, up 9.95% from fiscal 2024. In the quarter to June 2026, revenue grew 9.53%, EPS grew 65.4%, free cash flow grew 82.6% and total debt rose 1.96%, each against the same quarter a year earlier. Member of the S&P 500, Nasdaq 100 and Dow Jones; dividend growth for ten consecutive years, revenue growth for five.

414.87 7.43 +1.82%
Market cap
$224.3B
P/E
25.6×
Fwd P/E
22.7×
Dividend yield
2.40%
F-score
7/9
Altman Z
1.69
Beneish M
−2.27
Dividend safety
56/100
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
P/E ratio
22.84 34.20 23.68 21.48 21.72 18.56 18.62 15.34 67.30 14.61
Piotroski F-Score
7 5 5 6 6 6 6 8 6 8
P/S ratio
4.79 4.19 5.64 5.35 4.94 5.30 6.24 5.42 5.66 4.90
Altman Z-Score
1.69 1.26 1.34 1.77 1.83 2.10 2.29 2.36 2.61 2.62
Altman Z″-Score (non-manufacturers)
0.14 0.05 0.53 0.27 0.43 1.04 0.74 2.78 4.44 4.43
P/FCF ratio
22.97 14.05 22.98 16.86 16.14 14.25 18.01 12.71 12.84 12.28
Beneish M-Score
(2.27) (2.83) (2.26) (2.63) (2.65) (2.65) (2.18) (2.62) (3.02) (2.65)
P/Operating CF
109.85 29.34 295.73 53.14 45.67 62.58 58.01 40.29 42.96 36.37
Dividend Safety Score
56 — — — — — — — — —
P/B ratio
20.34 23.82 25.53 38.45 19.14 14.32 15.08 10.29 5.13 3.77
Price to Tangible BV
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 69.15 23.27
EV/Sales
6.03 5.63 7.55 6.47 5.91 6.18 7.14 5.61 5.39 4.75
EV/EBITDA
14.34 14.46 16.60 13.13 13.91 12.33 14.04 10.92 10.32 9.18
EV/Operating CF
22.25 16.37 25.12 17.53 16.58 14.96 18.23 11.80 11.01 10.55
EV/FCF
28.90 18.88 30.73 20.41 19.32 16.61 20.60 13.17 12.21 11.90
Quick Ratio
0.73 0.81 0.99 0.95 1.06 1.30 1.01 2.44 4.98 3.68
Current Ratio
1.14 1.26 1.65 1.41 1.59 1.81 1.44 2.79 5.49 4.11
Net Debt/EBITDA
2.94 3.70 4.19 2.28 2.29 1.75 1.77 0.38 (0.53) (0.29)
Debt/Assets
60.28% 65.44% 66.51% 59.80% 54.46% 52.40% 50.08% 51.09% 44.20% 44.57%
Debt/Equity
6.31 10.23 10.37 10.64 4.97 3.51 3.09 2.71 1.40 1.16
Asset Turnover
0.40 0.35 0.35 0.42 0.42 0.41 0.37 0.32 0.29 0.31
Operating CF/Net income
1.29 2.81 1.26 1.48 1.57 1.45 1.17 1.35 5.65 1.34
Capex/Depreciation
(0.29) (0.19) (0.23) (0.27) (0.26) (0.17) (0.28) (0.38) (0.34) (0.35)
Interest Coverage
3.30 2.30 2.75 6.80 6.38 7.24 7.51 7.37 7.65 7.77
ROE
106.10% 67.55% 135.79% 126.47% 73.16% 76.13% 70.73% 44.48% 7.18% 26.65%
ROA
8.45% 4.33% 8.28% 10.38% 9.50% 11.84% 12.44% 11.47% 2.51% 10.36%
ROIC
10.48% 8.40% 8.24% 17.95% 14.93% 17.99% 19.72% 37.46% 32.97% 23.20%
Return on Tangible Assets
67.16% 32.79% 37.57% 54.94% 47.58% 50.51% 74.45% 28.86% 4.35% 19.42%
Average Days of Receivables
95.05 74.06 94.11 77.14 68.77 64.96 63.39 55.03 51.71 50.25
Research and Development Expense of Revenue
19.79% 17.84% 16.97% 16.84% 18.55% 16.55% 17.62% 15.74% 15.59% 16.70%
Selling, General and Administrative Expense of Revenue
19.18% 21.23% 21.92% 20.57% 20.66% 22.54% 22.04% 22.45% 21.31% 22.02%
Intangible Assets out of Total Assets
0.45 0.50 0.53 0.49 0.49 0.50 0.57 0.33 0.29 0.32
Share Based Compensation of Revenue
1.34% 1.59% 1.53% 1.52% 1.31% 1.30% 1.32% 1.31% 1.44% 1.35%
Graham Net Nets
(0.30) (0.41) (0.38) (0.28) (0.27) (0.24) (0.22) (0.13) (0.04) (0.02)
Graham Number
72.03 43.32 57.38 43.18 52.34 66.90 68.25 73.48 45.20 96.30
Earnings Yield
4.38% 2.92% 4.22% 4.66% 4.61% 5.39% 5.37% 6.52% 1.49% 6.85%
Free Cash Flow Yield
4.35% 7.12% 4.35% 5.93% 6.20% 7.02% 5.55% 7.87% 7.79% 8.14%
Revenue per Share
68.31 62.24 52.69 48.93 45.58 43.39 38.61 35.93 31.26 30.74
Operating CF per Share
18.51 21.40 15.83 18.07 16.25 17.91 15.12 17.09 15.29 13.84
Capex per Share
(3.45) (2.04) (2.08) (1.74) (1.54) (1.04) (1.02) (1.12) (0.91) (0.99)
Free Cash Flow per Share
15.06 19.36 13.76 16.33 14.70 16.88 14.10 15.97 14.38 12.86
Cash per Share
16.97 22.30 20.46 17.30 14.10 18.17 14.73 44.33 57.02 50.92
Shareholders Equity per Share
16.09 10.94 11.65 6.80 11.75 16.06 15.99 18.91 34.53 39.94
Interest Debt per Share
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Book value per Share
16.09 10.94 11.65 6.80 11.75 16.06 15.99 18.91 34.53 39.94
Free Cash Flow
8,100.00 10,394.00 7,359.00 8,785.00 8,381.00 9,889.00 8,532.00 10,558.00 10,513.00 9,616.00
Working Capital
3,568.00 5,931.00 11,940.00 6,499.00 7,201.00 9,491.00 5,605.00 24,130.00 40,456.00 34,806.00
Capital Expenditures
(1,858.00) (1,096.00) (1,112.00) (936.00) (880.00) (608.00) (618.00) (738.00) (664.00) (738.00)
Net Current Asset Value
(52,871.00) (56,932.00) (60,590.00) (39,274.00) (35,080.00) (32,395.00) (31,594.00) (16,298.00) (5,237.00) (1,741.00)
EV/EBIT
24.40 25.91 26.94 17.81 20.09 17.19 17.25 12.99 12.34 11.16
Capex to Sales
0.05 0.03 0.04 0.04 0.03 0.02 0.03 0.03 0.03 0.03
Price to Operating Income
19.39 19.28 20.15 14.72 16.79 14.74 15.08 12.54 12.97 11.51
Other line items
Depreciation/Fixed assets
0.80 0.88 0.83 0.63 0.66 0.74 0.45 0.39 0.39 0.42
Cash ROIC
11.19% 13.33% 9.00% 16.92% 17.44% 18.64% 17.60% 13.94% 10.28% 9.38%
Accounts Receivable Turnover
4.50 4.76 4.39 5.03 5.52 5.93 6.12 6.97 7.14 7.46
Accounts Payable Turnover
5.63 7.35 5.35 4.36 4.63 4.41 3.38 3.21 3.59 4.42
Inventory Turnover
1.82 1.56 1.17 1.42 1.62 1.65 1.34 1.42 1.46 1.61
Average Days of Payables
71.77 54.16 68.67 89.57 77.25 84.21 114.88 107.43 121.28 80.42
Days of Inventory on Hand
188.76 198.65 411.08 280.90 231.08 230.71 300.31 261.67 254.22 240.73
Average Receivables
8,176.00 7,025.00 6,415.50 5,229.00 4,710.00 4,291.00 3,818.50 3,408.50 3,201.00 3,080.00
Average Payables
2,137.50 1,749.00 1,581.00 1,469.00 1,393.50 1,396.00 1,289.00 1,279.50 1,134.50 941.00
Average Inventory
6,611.50 8,258.00 7,224.00 4,508.00 3,989.50 3,738.50 3,262.00 2,887.00 2,789.50 2,590.00
Average Assets
91,212.50 94,496.50 81,137.50 63,143.00 62,056.50 61,327.50 63,061.50 73,185.00 78,790.00 74,537.50
Average Common Equity
7,267.50 6,054.50 4,946.50 5,180.50 8,054.50 9,541.00 11,086.50 18,870.50 27,558.00 28,979.00

Fold the line items

Columns are period end dates